Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis-Reference-Cited by-同舟云学术

Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis

Published:2019 Issue:4 Volume:68 Page:549-558
ISSN:1341-1357
Container-title:Experimental Animals
language:en
Short-container-title:Exp. Anim.

Author:

Liu Tianlong¹,Yang Fan²,Liu Jing¹,Zhang Mingjie¹,Sun Jianjun¹,Xiao Yunfeng³,Xiao Zhibin³,Niu Haiyan²,Ma Ruilian¹,Wang Yi¹,Liu Xiaolei³,Dong Yu⁴

Affiliation:

1. Department of Pharmacy, Affiliated Hospital of Inner Mongolia Medical University, No. 1 Tongdao North Street, Huimin District, Hohhot 010059, P.R. China

2. Department of Service Center, Health committee of Inner Mongolia Autonomous Region, No. 63 Xinhua Street, Xincheng District, Hohhot 010055, P.R. China

3. Department of Pharmacology, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010059, P.R. China

4. Department of Natural Medicinal Chemistry, College of Pharmacy, Inner Mongolia Medical University, Jinshan Development Zone, Hohhot 010110, P.R. China

Publisher

Japanese Association for Laboratory Animal Science

Subject

General Veterinary,General Biochemistry, Genetics and Molecular Biology,Animal Science and Zoology,General Medicine

Link

https://www.jstage.jst.go.jp/article/expanim/68/4/68_19-0037/_pdf

Reference45 articles.

1. 1. Althof N., Goetzke C.C., Kespohl M., Voss K., Heuser A., Pinkert S., Kaya Z., Klingel K. and Beling A. 2018. The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis. EMBO Mol. Med. 10: 200–218.

2. 2. Badorff C., Lee G.H., Lamphear B.J., Martone M.E., Campbell K.P., Rhoads R.E. and Knowlton K.U. 1999. Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 5: 320–326.

3. 3. Barry S.P., Townsend P.A., Latchman D.S. and Stephanou A. 2007. Role of the JAK-STAT pathway in myocardial injury. Trends Mol. Med. 13: 82–89.

4. 4. Belkaya S., Kontorovich A.R., Byun M., Mulero-Navarro S., Bajolle F., Cobat A., Josowitz R., Itan Y., Quint R., Lorenzo L., Boucherit S., Stoven C., Di Filippo S., Abel L., Zhang S.Y., Bonnet D., Gelb B.D. and Casanova J.L. 2017. Autosomal Recessive Cardiomyopathy Presenting as Acute Myocarditis. J. Am. Coll. Cardiol. 69: 1653–1665.

5. 5. Chen P., Xie Y., Shen E., Li G.G., Yu Y., Zhang C.B., Yang Y., Zou Y., Ge J., Chen R. and Chen H. 2011. Astragaloside IV attenuates myocardial fibrosis by inhibiting TGF-β1 signaling in coxsackievirus B3-induced cardiomyopathy. Eur. J. Pharmacol. 658: 168–174.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragali radix (Huangqi): a time-honored nourishing herbal medicine;Chinese Medicine;2024-08-30

2. Metabolomics combined with network pharmacology reveals a role for astragaloside IV in inhibiting enterovirus 71 replication via PI3K-AKT signaling;Journal of Translational Medicine;2024-06-10

3. Chinese herbal extracts with antiviral activity: evaluation, mechanisms, and potential for preventing PRV, PEDV and PRRSV infections;Animal Diseases;2023-10-26

4. A bibliometric and visual analysis of research trends and hotspots of myocardial apoptosis: A review;Medicine;2023-09-22

5. Pharmacological Effects of Astragaloside IV: A Review;Molecules;2023-08-18